Open
Actively Recruiting
NOLA (NeuWave Observational Liver Ablation) Registry
About
Brief Summary
This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.
Study Type
Phase
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Patients who underwent or are scheduled to undergo a microwave ablation of one or more liver lesions with the NEUWAVE Microwave Ablation System per the device's Instructions for Use (IFU).
- Patients with signed informed consent (or waiver approved by IRB/EC) who are willing to comply with the assessment schedule, and willing to have data included in the database.
- Patients greater than or equal to 22 years old at the time of informed consent (or waiver approved by IRB/EC).
Exclusion Criteria:
- Patients with a life expectancy of less than 1 year, in the opinion of the treating physician.
- Use of microwave ablation purely as a transection tool, rather than focused liver lesion ablation.
- Patient is currently participating, or planning to participate, in another NeuWave/Ethicon-funded clinical trial or registry studying microwave ablation in the liver. Note: roll-over patients from previous NeuWave trials are permitted.
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
19-001698
Category
Liver Cancer
Principal Investigator
Contact
Location
- UCLA Westwood